Direxion Daily NVDA Bear 1X Shares (NASDAQ: NVDD)

Últimas noticias sobre Direxion Daily NVDA Bear 1X Shares (NASDAQ:NVDD)

Direxion Daily NVDA Bear 1X Shares

Direxion

The Fund, under normal circumstances, invests in financial instruments, including swap agreements and options, that, in combination, provide 1X inverse (opposite) or short leveraged exposure to NVDA equal to at least 80% of the Funds net assets (plus borrowings for investment purposes).

Dreyfus Govt Cash Man Ins

Gs Financial Square Treasury Instruments Fund

Dreyfus Trsy Prime Cash Mgmt - In 0 -

Goldman Sachs Fin Gov 465 Institut

Nvidia traded at $113.76 on Wednesday, down 5.74%, and slipped further to $112.21 in after-hours trading, down 1.36%.  While Nvidia outperforms Intel Corp and Advanced Micro Devices Inc in growth and momentum, it lags in valuation metrics, according to Benzinga Edge rankings. For deeper insights, sign up for Benzinga Edge.

Long Ideas

Technicals

Exclusives

Tech

Trading Ideas

Interview

NVDA

NVDD

NVDU

Las acciones de Nvidia caen 29 % en 2025. Análisis técnico y temores sobre gasto en IA aumentan la presión. ¿Rebote o más caídas?

Acciones de Nvidia (NVDA) caen un 29 % en 2025: ¿Fin de la racha ganadora en inteligencia artificial?

<a href="https://www.youtube.com/watch?v=sk9Yovro9kE">https://www.youtube.com/watch?v=sk9Yovro9kE</a>

News

President Trump Says Will Sign AI Order To Fast Track Big Projects

<ul>
<li>Cboe will maintain presence in Japan for its Global Derivatives and Cboe Data Vantage businesses</li>
</ul>
CHICAGO and TOKYO, July 23, 2025 /PRNewswire/ --&nbsp;Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, today announced its decision to wind down its Japanese equities business, including the operations of its Cboe Japan proprietary trading system and Cboe BIDS Japan block trading platform. Cboe expects to suspend operations for these businesses on August 29, 2025 and formally close the businesses subject to consultation with regulators.
The decision to close this business reflects Cboe's disciplined strategy to steward resources towards opportunities that deliver the best potential returns for shareholders and was taken in the context of evolving business conditions, which challenged the financial sustainability of maintaining operations of Cboe's equities business in the country.

CBOE

Cboe Plans To Cease Japanese Equities Operations; To Suspend Japanese Equities Operations On August 29, 2025; Wind Down Will Have Immaterial Impact On Cboe's Organic Total Net Revenue Growth 2025 Guidance

Guidance

INBK

Reuters Cites First Internet Bancorp Presentation Saying Co Sees FY26 Net Interest Income $158M-$163M; Outlook Q3 Net Interest Income About $33.5M; Outlook Q4 Net Interest Income About $35.5M

Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) shares are trading at $97.99, after a 1.52% increase. Moreover, over the past month, the stock increased by 5.16%, but in the past year, fell by 12.03%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1753308023_0.png" alt="Past Year Chart" />

<h3>Zimmer Biomet Holdings P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 52.39 in the Health Care Equipment &amp; Supplies industry, Zimmer Biomet Holdings Inc. has a lower P/E ratio of 21.45. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1753308023_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

P/E Ratio Insights for Zimmer Biomet Holdings

TSLA

During Conference Call, Tesla CFO Says Cost Of Tariffs Increased Sequentially By $300M In Q2, Two-Thirds Of Which Affected Automotive; Tariff Costs Will Continue To Increase In Near-term

General

During Conference Call, Tesla CEO Musk Says Unsupervised FSD Likely To Be Available For Personal Use By End Of Year

During Conference Call, Tesla CFO Says Tesla May Not Be Able To Guarantee Delivery Of Orders Placed After August Due To Expiring EV Credit; Tesla Facing Limited Supply Of Vehicles Due To Budget Bill's EV Credit Repeal; Latest Capex Expectation For The Year In Excess Of $9B

180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) reported quarterly losses of $(0.30) per share. This is a 3100 percent decrease over earnings of $0.01 per share from the same period last year.

Earnings

ATNF

180 Life Sciences Q2 EPS $(0.30) Down From $0.01 YoY

PB Bankshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBBK#NASDAQ">PBBK</a>) reported quarterly earnings of $0.27 per share. This is a 68.75 percent increase over earnings of $0.16 per share from the same period last year. The company reported $3.554 million in sales this quarter. This is a 19.42 percent increase over sales of $2.976 million the same period last year.

PBBK

PB Bankshares Q2 EPS $0.27 Up From $0.16 YoY, Sales $3.554M Up From $2.976M YoY

During Conference Call, Tesla CFO Vaibhav Taneja Says Legislation Changes Will Impact Sales Of Regulatory Credits; Production Ramp Up Of Cheaper Car Will Happen Next Quarter Slower Than Initially Expected; The Big Bill Has Certain Adverse Impacts, Even For The Energy Business

Southern Missouri Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMBC#NASDAQ">SMBC</a>) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.26 by 10.32 percent. This is a 16.81 percent increase over earnings of $1.19 per share from the same period last year. The company reported quarterly sales of $47.613 million which beat the analyst consensus estimate of $46.297 million by 2.84 percent. This is a 11.08 percent increase over sales of $42.862 million the same period last year.

Earnings Beats

Earnings Misses

SMBC

Southern Missouri Bancorp Q4 EPS $1.39 Beats $1.26 Estimate, Sales $47.613M Beat $46.297M Estimate

During Conference Call, Tesla CEO Elon Musk Says Co Is Working To Unblock Regulatory Challenges For Supervised FSD In China; Retooling For Optimus 3, Prototypes Will Be Ready This Year And Production At Scale Next Year

CSX Says On July 10, Sec Indicated It Concluded Investigation Into Accounting Restatement, Does Not Intend To Recommend Enforcement Action; Expects Impact Of Applying Provision Related To OBBBA To Result In Favorable Cash Tax Impacts Of About $250M For 2025 Tax Year

Offerings

ADVB

Advanced Biomed  Files For Offering Of Up To 40M Shares Of Common Stock By Selling Stockholder

<a href="https://nypost.com/2025/07/23/media/jeff-bezos-has-been-weighing-a-possible-acquisition-of-cnbc-sources/" title="https://nypost.com/2025/07/23/media/jeff-bezos-has-been-weighing-a-possible-acquisition-of-cnbc-sources/">https://nypost.com/2025/07/23/media/jeff-bezos-has-been-weighing-a-possible-acquisition-of-cnbc-sources/</a>

CMCSA

"Jeff Bezos weighing possible acquisition of CNBC cable network: sources" - NY Post

Mid Penn Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPB#NASDAQ">MPB</a>) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.47 by 49.57 percent. This is a 2.94 percent increase over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $54.349 million which beat the analyst consensus estimate of $53.533 million by 1.52 percent. This is a 23.25 percent increase over sales of $44.095 million the same period last year.

Mid Penn Bancorp Q2 Adj. EPS $0.70 Beats $0.47 Estimate, Sales $54.349M Beat $53.533M Estimate

Macro Economic Events

Politics

Economics

During Conference Call, Tesla CEO Elon Musk Says Sales In Europe Will Improve Significantly Once Supervised Full-Self Driving Is Approved; Energy Segment Growing Very Well Despite Headwinds From Tariffs

Citigroup analyst Nicholas Joseph maintains Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>) with a Buy and lowers the price target from $150 to $140.

Price Target

Analyst Ratings

Citigroup Maintains Buy on Prologis, Lowers Price Target to $140

During Conference Call, Tesla CEO Elon Musk Says Will Probably Have Autonomous Ride Hailing In Probably Half Of The Population Of The US by The End Of Year;  Looking For Robotaxi Regulatory Approvals In San Francisco Bay Area, Nevada, Arizona, Florida And Other Places; Close To Getting Regulatory Approval For Supervised FSD In Netherlands

Declaration of Dividend The Board of Directors declared a quarterly cash dividend of $0.07 per share, payable on August 20, 2025, to shareholders of record as of August 6, 2025.

Dividends

NBBK

NB Bancorp Initiates Quarterly Cash Dividend Of $0.07 Per Share

Comments

Direxion Daily NVDA Bear 1X Shares

Noticias

Últimas noticias sobre Direxion Daily NVDA Bear 1X Shares (NASDAQ:NVDD)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL